Literature DB >> 26070045

Cellular models to study bipolar disorder: A systematic review.

Biju Viswanath1, Sam P Jose2, Alessio Squassina3, Jagadisha Thirthalli4, Meera Purushottam4, Odity Mukherjee5, Vladimir Vladimirov6, George P Patrinos7, Maria Del Zompo8, Sanjeev Jain9.   

Abstract

BACKGROUND: There is an emerging interest in the use of cellular models to study psychiatric disorders. We have systematically reviewed the application of cellular models to understand the biological basis of bipolar disorder (BD).
METHOD: Published scientific literature in MEDLINE, PsychINFO and SCOPUS databases were identified with the following search strategy: [(Lymphoblastoid OR Lymphoblast OR Fibroblast OR Pluripotent OR Olfactory epithelium OR Olfactory mucosa) AND (Bipolar disorder OR Lithium OR Valproate OR Mania)]. Studies were included if they had used cell cultures derived from BD patients.
RESULTS: There were 65 articles on lymphoblastoid cell lines, 14 articles on fibroblasts, 4 articles on olfactory neuronal epithelium (ONE) and 2 articles on neurons reprogrammed from induced pluripotent stem cell lines (IPSC). Several parameters have been studied, and the most replicated findings are abnormalities in calcium signaling, endoplasmic reticulum (ER) stress response, mitochondrial oxidative pathway, membrane ion channels, circadian system and apoptosis related genes. These, although present in basal state, seem to be accentuated in the presence of cellular stressors (e.g. oxidative stress--rotenone; ER stress--thapsigargin), and are often reversed with in-vitro lithium.
CONCLUSION: Cellular modeling has proven useful in BD, and potential pathways, especially in cellular resilience related mechanisms have been identified. These findings show consistency with other study designs (genome-wide association, brain-imaging, and post-mortem brain expression). ONE cells and IPSC reprogrammed neurons represent the next generation of cell models in BD. Future studies should focus on family-based study designs and combine cell models with deep sequencing and genetic manipulations.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Cell model; Fibroblast; Lymphoblast; Olfactory; Pluripotent

Mesh:

Substances:

Year:  2015        PMID: 26070045     DOI: 10.1016/j.jad.2015.05.037

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  21 in total

Review 1.  The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine.

Authors:  Claudia Pisanu; Urs Heilbronner; Alessio Squassina
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

2.  Na+/K+-ATPase level and products of lipid peroxidation in live cells treated with therapeutic lithium for different periods in time (1, 7, and 28 days); studies of Jurkat and HEK293 cells.

Authors:  Miroslava Vosahlikova; Lenka Roubalova; Hana Ujcikova; Martina Hlouskova; Stanislav Musil; Martin Alda; Petr Svoboda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-02-21       Impact factor: 3.000

3.  Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence.

Authors:  Brandi L Rollins; Ling Morgan; Brooke E Hjelm; Adolfo Sequeira; Alan F Schatzberg; Jack D Barchas; Francis S Lee; Rick M Myers; Stanley J Watson; Huda Akil; Steven G Potkin; William E Bunney; Marquis P Vawter
Journal:  Mol Neuropsychiatry       Date:  2017-11-30

4.  Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder.

Authors:  Claudia Pisanu; Donatella Congiu; Marta Costa; Caterina Chillotti; Raffaella Ardau; Giovanni Severino; Andrea Angius; Urs Heilbronner; Liping Hou; Francis J McMahon; Thomas G Schulze; Maria Del Zompo; Alessio Squassina
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-10-14       Impact factor: 3.568

5.  CADPS functional mutations in patients with bipolar disorder increase the sensitivity to stress.

Authors:  Jérémy Sitbon; Dennis Nestvogel; Caroline Kappeler; Aude Nicolas; Stephanie Maciuba; Annabelle Henrion; Réjane Troudet; Elisa Courtois; Gaël Grannec; Violaine Latapie; Caroline Barau; Philippe Le Corvoisier; Nicolas Pietrancosta; Chantal Henry; Marion Leboyer; Bruno Etain; Marika Nosten-Bertrand; Thomas F J Martin; JeongSeop Rhee; Stéphane Jamain
Journal:  Mol Psychiatry       Date:  2022-02-15       Impact factor: 15.992

6.  Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder.

Authors:  Joanne H Huang; Shaunna S Berkovitch; Jonathan Iaconelli; Bradley Watmuff; Hyoungjun Park; Shrikanta Chattopadhyay; Donna McPhie; Dost Öngür; Bruce M Cohen; Clary B Clish; Rakesh Karmacharya
Journal:  Mol Neuropsychiatry       Date:  2016-06-24

7.  Synchronized time-keeping is key to healthy mood regulation (Commentary on Landgraf et al.).

Authors:  Jennifer A Davis; Karen L Gamble
Journal:  Eur J Neurosci       Date:  2016-01-13       Impact factor: 3.386

Review 8.  Concise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders.

Authors:  David M Panchision
Journal:  Stem Cells       Date:  2016-02-11       Impact factor: 6.277

9.  Mitochondrial Alterations in Fibroblasts of Early Stage Bipolar Disorder Patients.

Authors:  Ana P Marques; Rosa Resende; Diana F Silva; Mariana Batista; Daniela Pereira; Brigite Wildenberg; Sofia Morais; António Macedo; Cláudia Pais; Joana B Melo; Nuno Madeira; Cláudia F Pereira
Journal:  Biomedicines       Date:  2021-05-07

Review 10.  Innovative approaches to bipolar disorder and its treatment.

Authors:  Paul J Harrison; Andrea Cipriani; Catherine J Harmer; Anna C Nobre; Kate Saunders; Guy M Goodwin; John R Geddes
Journal:  Ann N Y Acad Sci       Date:  2016-02       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.